Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Outsourcing Facilities Need More Regulatory Transparency From FDA To Compound Drugs In Shortage
Jul 02 2020
•
By
Joanne S. Eglovitch
Report Cites Reasons Why Outsourcing Facilities Not Compounding Drugs In Shortage • Source: Shutterstock
More from Manufacturing
More from Compliance